These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30454833)

  • 21. Candidates for liver transplantation with alcoholic liver disease: Psychosocial aspects.
    Telles-Correia D; Mega I
    World J Gastroenterol; 2015 Oct; 21(39):11027-33. PubMed ID: 26494959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of behavioral alcohol interventions for transplant candidates and recipients with alcohol-related liver disease.
    Schlagintweit HE; Lynch MJ; Hendershot CS
    Am J Transplant; 2019 Oct; 19(10):2678-2685. PubMed ID: 31419015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival and predictors of relapse and survival after liver transplantation for alcoholic liver disease.
    Lindenger C; Castedal M; Schult A; Åberg F
    Scand J Gastroenterol; 2018 Dec; 53(12):1553-1561. PubMed ID: 30678557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol withdrawal alleviates adipose tissue inflammation in patients with alcoholic liver disease.
    Voican CS; Njiké-Nakseu M; Boujedidi H; Barri-Ova N; Bouchet-Delbos L; Agostini H; Maitre S; Prévot S; Cassard-Doulcier AM; Naveau S; Perlemuter G
    Liver Int; 2015 Mar; 35(3):967-78. PubMed ID: 24766056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcohol-Related Liver Disease Including New Developments.
    Patel PV; Flamm SL
    Clin Liver Dis; 2023 Feb; 27(1):157-172. PubMed ID: 36400463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Good outcome after liver transplantation for ALD without a 6 months abstinence rule prior to transplantation including post-transplant CDT monitoring for alcohol relapse assessment - a retrospective study.
    Kollmann D; Rasoul-Rockenschaub S; Steiner I; Freundorfer E; Györi GP; Silberhumer G; Soliman T; Berlakovich GA
    Transpl Int; 2016 May; 29(5):559-67. PubMed ID: 26865285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives.
    Liu SY; Tsai IT; Hsu YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy of alcoholic liver disease in clinical practice.
    Rosato V; Abenavoli L; Federico A; Masarone M; Persico M
    Int J Clin Pract; 2016 Feb; 70(2):119-31. PubMed ID: 26709723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term treatment of alcoholism].
    Koller G
    Fortschr Neurol Psychiatr; 2013 Nov; 81(11):655-65; quiz 666. PubMed ID: 24194059
    [No Abstract]   [Full Text] [Related]  

  • 30. Alcohol and the liver.
    Willner IR; Reuben A
    Curr Opin Gastroenterol; 2005 May; 21(3):323-30. PubMed ID: 15818153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA).
    Testino G; Vignoli T; Patussi V; Allosio P; Amendola MF; Aricò S; Baselice A; Balbinot P; Campanile V; Fanucchi T; Greco G; Macciò L; Meneguzzi C; Mioni D; Palmieri VO; Parisi M; Renzetti D; Rossin R; Gandin C; Bottaro LC; Bernardi M; Addolorato G; Lungaro L; Zoli G; Scafato E; Caputo F
    Dig Dis Sci; 2022 Jun; 67(6):1975-1986. PubMed ID: 34142284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis.
    Mellinger JL; Scott Winder G; DeJonckheere M; Fontana RJ; Volk ML; Lok ASF; Blow FC
    J Subst Abuse Treat; 2018 Aug; 91():20-27. PubMed ID: 29910011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lifetime drinking history in patients with alcoholic liver disease and patients with alcohol use disorder without liver disease.
    Nielsen JK; Olafsson S; Bergmann OM; Runarsdottir V; Hansdottir I; Sigurdardottir R; Björnsson ES
    Scand J Gastroenterol; 2017; 52(6-7):762-767. PubMed ID: 28276826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Established therapies and new therapeutic strategies in alcoholic liver disease].
    Seitz HK; Mueller S
    Z Gastroenterol; 2017 Mar; 55(3):291-303. PubMed ID: 27923259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacological treatment of alcohol dependence: needs and possibilities.
    Mann K
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():55-8. PubMed ID: 8737001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unhealthy Alcohol Use.
    Holt S; Tetrault J
    Clin Liver Dis; 2016 Aug; 20(3):429-44. PubMed ID: 27373607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease.
    Da BL; Im GY; Schiano TD
    Hepatology; 2020 Sep; 72(3):1102-1108. PubMed ID: 32369624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of alcohol recurrence before and after liver transplantation.
    Marroni CA
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1():S109-14. PubMed ID: 26193869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver disease in alcohol abusers: clinical perspective.
    Diehl AM
    Alcohol; 2002 May; 27(1):7-11. PubMed ID: 12062630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Call to Standardize Definitions, Data Collection, and Outcome Assessment to Improve Care in Alcohol-Related Liver Disease.
    Shen NT; Salajegheh A; Brown RS
    Hepatology; 2019 Sep; 70(3):1038-1044. PubMed ID: 30802988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.